7 KILLED, HUNDREDS INJURED AS STRONG QUAKE HITS SULAWESI, INDONESIA
VATICAN: POPE FRANCIS, FORMER POPE BENEDICT BOTH GET COVID-19 VACCINE
AUSTRALIA REBUKES GOOGLE FOR BLOCKING LOCAL CONTENT
JAPAN TO BAN ENTRY OF FOREIGN ATHLETES TO TRAIN AHEAD OF SUMMER OLYMPICS
BIDEN INAUGURATION WILL FEATURE DIVERSE PERFORMANCES INCLUDING LADY GAGA, JENNIFER LOPEZ
COURT ORDERS ARREST OF COPS ACCUSED OF KILLING ARMY MEN IN JOLO
THE PANDEMIC SLAMS PHL VEHICLE SALES IN 2020
CHESS PLAYER WESLEY SO BAGS P11.8M, JOINS WORLD’S TOP ESPORT EARNERS
ZSA ZSA PADILLA FINALLY VISITS THE GRAVE OF ‘COMEDY KING’ DOLPHY AGAIN
DUTERTE: PRESIDENCY JOB NOT FOR A WOMEN

W.H.O IN TALKS WITH PFIZER, MODERNA ON COVID-19 VACCINE ACCESS

3 months ago | World | 0 comments

By Xai Reyes

The World Health Organization (WHO) said Tuesday it is in discussions with Pfizer and Moderna about possibly including their high-tech coronavirus vaccines among early jabs for poor countries at affordable prices.

The WHO-backed Covax facility, created to ensure equitable access to coronavirus disease 2019 (COVID-19) vaccines around the world as they become available, is aiming to provide some two billion doses by the end of next year.

It has already secured hundreds of millions of doses of vaccine candidates being developed by AstraZeneca, Novavax and Sanofi-GSK.

WHO senior advisor Bruce Aylward said the organization was looking at a range of other jabs, as well as the current frontrunners.

0 Comments

Submit a Comment

Your email address will not be published.

Social Media